Granules India profit surges as higher sales outweigh cost pressures

Granules India’s Q2 net up 39% at ₹182 crore

Granules India's Q2 net profit rose 39% to ₹182 crore on 20% revenue growth to ₹1,560 crore, amid higher costs and a constructive USFDA audit.

Granules India net profit rises 39% to ₹182 cr on higher revenue

Revenue crosses ₹1,500 crore despite higher input and logistics costs driven by West Asia tensions, expect cost pressures to persist, says CMD Chigurupati

Granules India profit surges as higher sales outweigh cost pressures

Nov 2 (Reuters) - Indian drugmaker Granules India reported a second-quarter profit rise of nearly 40% on Monday, ​as new product launches and ‌strong sales of its main medicines in key overseas markets outweighed higher production costs. Consolidated n...